Clinical Trial

Total Periarticular Infiltration Vs Posterior Periarticular Infiltration Plus PENG Block for Hip Analgesia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
In a recent study, direct periarticular local anesthetic infiltration (PAI) showed a greater incidence of early quadriceps weakness (33% at 3 hours and 13% at 6 hours) than pericapsular nerve group block (PENGB) in total hip arthroplasty (THA) but, in turn, demonstrated a statistically significant better pain control. Additionally, PENGB could not completely circumvent motor compromise either, particularly at 3 hours (20% incidence), probably secondary to an injectate migration towards the femoral nerve. Posteriorly to this publication, a cadaveric trial looking into the maximum effective volume that spared the femoral nerve resulted in 13.2 mL. This newer evidence led to the design of a strategy that combines both interventions, aiming to obtain the best of them and have a solid alternative for those cases where very early mobilization is pursued. Thus, it is hypothesized that posterior PAI added to a low-volume PENGB (10mL) represents a superior alternative to PAI in terms of strength preservation and provides effective analgesia during the first 24 postoperative hours after THA.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-03; most recent amendment 2025-01-15.
Status change: Not Yet Recruiting → Recruiting 2023-10-18
Trial Details
NCT Number NCT06075004
Lead Sponsor University of Chile
Conditions Hip Osteoarthritis, Postoperative Pain
Enrollment 74 participants
Start Date 2023-10-18
Primary Completion 2025-10-15 (estimated)
Study Completion 2025-10-23 (estimated)
Updated on ClinicalTrials.gov 2025-01-17